CDKN2A and squamous cell intraepithelial neoplasia: A distinction is made between low-grade squamous intraepithelial lesions (LSILs, formerly p16-negative AIN1 and AIN2) and high-grade squamous intraepithelial lesions (HSILs, formerly p16-positive AIN2 and AIN3) [5].